GRAL
GRAIL, Inc.Company Information
- Company Name
- GRAIL, Inc.
- CIK
- CIK0001699031
- Category
- Non-accelerated filer<br>Emerging growth company
- Ticker: Exchange
- GRAL: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8071
- SIC Description
- Services-Medical Laboratories
- Ticker
- GRAL
SEC filing data through
Insider Sentiment
- Last purchase
- 2024-10-09
- Last sale
- 2026-09-21
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 1,572,012
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 37,957,270
- Shares outstanding
- 43,112,595
- Ownership
- 88.04%
Earnings Market Reaction
- Filing date
- 2026-08-06
- Price on filing date
- —
- 1-month reaction
- 26.18%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||
| Nonrelated Party | - | - | - | - | - | - | - | 2 | 13 | ||||||
| Cash And Cash Equivalents At Carrying Value | 56 | 69 | 250 | 127 | 127 | 134 | 214 | 854 | 959 | ||||||
| Debt Securities Available For Sale Excluding Accrued Interest Current | 806 | 754 | 655 | 413 | 475 | 541 | 549 | - | - | ||||||
| Accounts Receivable Net Current | 20 | 20 | 18 | 16 | 16 | 19 | 20 | - | - | ||||||
| Supplies | 18 | 17 | 16 | 18 | 20 | 19 | 19 | - | - | ||||||
| Prepaid Expense And Other Assets Current | 16 | 17 | 15 | 15 | 13 | 15 | 17 | - | - | ||||||
| Assets Current | 915 | 877 | 954 | 589 | 652 | 728 | 820 | 910 | 1,019 | ||||||
| Property Plant And Equipment Net | 44 | 48 | 52 | 56 | 60 | 65 | 69 | - | - | ||||||
| Operating Lease Right Of Use Asset | 45 | 48 | 52 | 56 | 60 | 62 | 66 | 71 | 75 | ||||||
| Restricted Cash Noncurrent | 7 | 7 | 7 | 7 | 3 | 3 | 3 | 4 | 4 | ||||||
| Intangible Assets Net Excluding Goodwill | 1,781 | 1,816 | 1,851 | 1,885 | 1,920 | 1,982 | 2,017 | 2,051 | 2,086 | ||||||
| Other Assets Noncurrent | 7 | 7 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | ||||||
| Goodwill | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Assets | 2,844 | 2,803 | 2,922 | 2,601 | 2,703 | 2,848 | 2,983 | 3,118 | 3,270 | ||||||
| Accrued Liabilities Current | - | - | - | - | - | - | - | - | 57 | ||||||
Liabilities Current | |||||||||||||||
| Accounts Payable Current | 7 | 5 | 2 | 3 | 6 | 6 | 5 | - | - | ||||||
| Accrued Liabilities Current And Noncurrent | 64 | 58 | 64 | 58 | 49 | 54 | 57 | - | - | ||||||
| Operating Lease Liability Current | 45 | 10 | 12 | 14 | 14 | 13 | 13 | 14 | 14 | ||||||
| Other Liabilities Current | 1 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | ||||||
| Deferred Compensation Liability Current | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Liabilities Current | 84 | 75 | 80 | 77 | 71 | 75 | 77 | 94 | 88 | ||||||
| Operating Lease Liability Noncurrent | 81 | 41 | 43 | 45 | 48 | 51 | 55 | 59 | 62 | ||||||
| Deferred Income Tax Liabilities Net | 134 | 184 | 219 | 236 | 266 | 305 | 346 | 375 | 422 | ||||||
| Other Liabilities Noncurrent | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | ||||||
| Liabilities | 301 | 303 | 344 | 361 | 388 | 434 | 480 | 530 | 575 | ||||||
Stockholders Equity | |||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 12,956 | 12,804 | 12,787 | 12,350 | 12,336 | 12,322 | 12,305 | 12,292 | 12,274 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 2 | 2 | 3 | 2 | 2 | 2 | 1 | 2 | 1 | ||||||
| Retained Earnings Accumulated Deficit | -10,415 | -10,305 | -10,212 | -10,113 | -10,024 | -9,910 | -9,803 | -9,706 | -9,581 | ||||||
| Members Capital | - | - | - | - | - | - | 0 | - | 0 | ||||||
| Stockholders Equity | 2,543 | 2,501 | 2,578 | 2,240 | 2,315 | 2,414 | 2,503 | 2,588 | 2,695 | ||||||
| Liabilities And Stockholders Equity | 2,844 | 2,803 | 2,922 | 2,601 | 2,703 | 2,848 | 2,983 | 3,118 | 3,270 | ||||||
| Related Party | - | - | 0 | -0 | -0 | 0 | 0 | 2 | 13 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 50 | 50 | 50 | 50 | 50 | 50 | 50 | 50 | - | ||||||
| Members Equity | - | - | - | - | - | - | 2,503 | - | - | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Common Stock Shares Authorized | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 | - | ||||||
| Common Stock Shares Issued | 45 | 41 | 40 | 36 | 36 | 35 | 34 | 33 | 0 | ||||||
| Shares Outstanding | 45 | 41 | - | 36 | 36 | 35 | 34 | 33 | 0 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialGRAIL, Inc. (GRAL) — SEC Financial Statements & Analysis
GRAIL, Inc. (GRAL) is a services-medical laboratories company, incorporated in DE. GRAIL, Inc. trades on Nasdaq as: GRAL. GRAIL, Inc. (GRAL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06. Based on that filing, GRAIL, Inc. carries a market cap of $2.94B, a P/E ratio of -7.52x, a P/B ratio of 1.16x, a P/S ratio of 17.81x, an enterprise value of $2.88B, and an EV/EBITDA multiple of -5.32x. On profitability, it posts a gross margin of 50.76%, an operating margin of -338.40%, a net margin of -236.95%, a Return on Equity (ROE) of -16.12%, a Return on Assets (ROA) of -14.12%, and a Return on Invested Capital (ROIC) of -23.95%. Per share, it reports EPS of $-9.08, diluted EPS of $-9.08, free cash flow per share of $-6.87, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 2.64% year-over-year, net income growth of -40.84% year-over-year, and EPS growth of -50.88% year-over-year. On the balance sheet, it maintains a current ratio of 10.95x, a quick ratio of 10.76x, working capital of $831.18M, a debt-to-equity ratio of 0.12x, a debt ratio of 0.11, free cash flow of $-296.16M (TTM), and net debt of $-62.62M. Figures sourced from SEC EDGAR.
- Market Cap
- $2.94B
- P/E TTM
- -7.52x
- EPS TTM
- $-9.08
- P/B TTM
- 1.16x
- ROE TTM
- -16.12%
- ROA TTM
- -14.12%
- Debt To Equity
- 0.12x
- Free Cash Flow TTM
- $-296.16M
- Net Revenue TTM Growth 1Y
- 2.64%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is GRAIL, Inc. in?
GRAIL, Inc. (GRAL) operates in the Services-Medical Laboratories industry.
What exchange does GRAL trade on?
GRAIL, Inc. (GRAL) trades on the Nasdaq.
Where is GRAIL, Inc. incorporated?
GRAIL, Inc. is incorporated in DE.
When was GRAIL, Inc. (GRAL)'s most recent SEC filing?
GRAIL, Inc. (GRAL)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-06.
What is GRAL's market cap?
GRAIL, Inc. (GRAL) has a market capitalization of $2.94B as of 2026-06-30.
What is GRAL's EPS (earnings per share)?
GRAIL, Inc. (GRAL)'s trailing twelve month EPS is $-9.08 as of 2026-06-30.
What is GRAL's ROE (return on equity)?
GRAIL, Inc. (GRAL)'s trailing twelve month Return on Equity (ROE) is -16.12% as of 2026-06-30.
What is GRAL's ROA (return on assets)?
GRAIL, Inc. (GRAL)'s trailing twelve month Return on Assets (ROA) is -14.12% as of 2026-06-30.
What is GRAL's ROIC (return on invested capital)?
GRAIL, Inc. (GRAL)'s trailing twelve month Return on Invested Capital (ROIC) is -23.95% as of 2026-06-30.
What is GRAL's EV/EBITDA?
GRAIL, Inc. (GRAL)'s trailing twelve month EV/EBITDA is -5.32x as of 2026-06-30.